Harrow, Inc. Diluted Shares Outstanding (Weighted Average)
Harrow, Inc. (HROW) reported Diluted Shares Outstanding (Weighted Average) of 37.35 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-10
- Harrow, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 37.35M shares, a 3.87% decline year-over-year.
- Harrow, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 37.23M shares, a 3.92% increase year-over-year.
- Harrow, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 37.28M shares, a 4.10% increase year-over-year.
- Harrow, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 38.88M shares, a 8.89% increase year-over-year.
- Harrow, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 36.76M shares, a 3.11% increase from fiscal 2024.
- Harrow, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 35.65M shares, a 9.30% increase from fiscal 2023.
- Harrow, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 32.62M shares, a 18.78% increase from fiscal 2022.
- Harrow, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 27.46M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 37.35M shares 10-Q · filed 2026-08-10 | 37.29M shares 10-Q · filed 2026-08-10 | 37.29M shares derived: average of 3 quarters · filed 2026-08-10 | 37.68M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | 37.23M shares 10-Q · filed 2026-05-11 | 37.25M shares derived: average of 2 quarters · filed 2026-05-11 | 37.79M shares derived: average of 3 quarters · filed 2026-05-11 | 38.06M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | 37.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 38.08M shares derived: average of 2 quarters · filed 2026-03-02 | 38.34M shares derived: average of 3 quarters · filed 2026-08-10 | 36.76M shares 10-K · filed 2026-03-02 | |
| 2025-09-30 | 38.88M shares 10-Q · filed 2025-11-10 | 38.86M shares derived: average of 2 quarters · filed 2026-08-10 | 36.59M shares 10-Q · filed 2025-11-10 | 37.34M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | 38.85M shares 10-Q · filed 2026-08-10 | 36.30M shares 10-Q · filed 2026-08-10 | 36.83M shares derived: average of 3 quarters · filed 2026-08-10 | 36.55M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | 35.83M shares 10-Q · filed 2026-05-11 | 35.82M shares derived: average of 2 quarters · filed 2026-05-11 | 35.78M shares derived: average of 3 quarters · filed 2026-05-11 | 35.74M shares derived: average of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | 35.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 35.76M shares derived: average of 2 quarters · filed 2026-03-02 | 35.71M shares derived: average of 3 quarters · filed 2026-03-02 | 35.65M shares 10-K · filed 2026-03-02 | |
| 2024-09-30 | 35.70M shares 10-Q · filed 2025-11-10 | 35.66M shares derived: average of 2 quarters · filed 2025-11-10 | 35.60M shares 10-Q · filed 2025-11-10 | 35.55M shares derived: average of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | 35.62M shares 10-Q · filed 2025-08-11 | 35.54M shares 10-Q · filed 2025-08-11 | 35.50M shares derived: average of 3 quarters · filed 2026-03-02 | 35.19M shares derived: average of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | 35.47M shares 10-Q · filed 2025-05-08 | 35.43M shares derived: average of 2 quarters · filed 2026-03-02 | 35.04M shares derived: average of 3 quarters · filed 2026-03-02 | 33.90M shares derived: average of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | 35.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 34.83M shares derived: average of 2 quarters · filed 2026-03-02 | 33.37M shares derived: average of 3 quarters · filed 2026-03-02 | 32.62M shares 10-K · filed 2026-03-02 | |
| 2023-09-30 | 34.26M shares 10-Q · filed 2024-11-14 | 32.36M shares derived: average of 2 quarters · filed 2024-11-14 | 31.69M shares 10-Q · filed 2024-11-14 | 30.74M shares derived: average of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | 30.46M shares 10-Q · filed 2024-08-07 | 30.38M shares 10-Q · filed 2024-08-07 | 29.57M shares derived: average of 3 quarters · filed 2024-08-07 | 29.02M shares derived: average of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | 30.29M shares 10-Q · filed 2024-05-13 | 29.13M shares derived: average of 2 quarters · filed 2024-05-13 | 28.53M shares derived: average of 3 quarters · filed 2024-05-13 | 28.23M shares derived: average of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | 27.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 27.66M shares derived: average of 2 quarters · filed 2024-03-19 | 27.54M shares derived: average of 3 quarters · filed 2024-03-19 | 27.46M shares 10-K · filed 2024-03-19 | |
| 2022-09-30 | 27.35M shares 10-Q · filed 2023-11-13 | 27.33M shares derived: average of 2 quarters · filed 2023-11-13 | 27.29M shares 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | 27.30M shares 10-Q · filed 2023-08-09 | 27.27M shares 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | 27.23M shares 10-Q · filed 2023-05-11 | ||||
| 2021-09-30 | 27.11M shares 10-Q · filed 2021-11-09 | 26.63M shares 10-Q · filed 2021-11-09 | |||
| 2021-03-31 | 27.48M shares 10-Q · filed 2022-05-05 | 26.71M shares derived: average of 2 quarters · filed 2022-05-05 | 26.84M shares derived: average of 3 quarters · filed 2022-05-05 | 26.60M shares derived: average of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | 25.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | 26.51M shares derived: average of 2 quarters · filed 2021-11-09 | 26.31M shares derived: average of 3 quarters · filed 2021-11-09 | 25.90M shares 10-K · filed 2021-03-08 | |
| 2020-09-30 | 27.09M shares 10-Q · filed 2021-11-09 | 26.49M shares derived: average of 2 quarters · filed 2021-11-09 | 25.88M shares 10-Q · filed 2021-11-09 | 27.28M shares derived: average of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | 25.89M shares 10-Q · filed 2020-08-10 | 25.87M shares 10-Q · filed 2020-08-10 | 27.34M shares derived: average of 3 quarters · filed 2021-05-11 | 26.90M shares derived: average of 4 quarters · filed 2021-05-11 | |
| 2020-03-31 | 25.87M shares 10-Q · filed 2021-05-11 | 28.06M shares derived: average of 2 quarters · filed 2021-05-11 | 27.23M shares derived: average of 3 quarters · filed 2021-05-11 | 26.73M shares derived: average of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | 30.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | 27.92M shares derived: average of 2 quarters · filed 2021-03-08 | 27.02M shares derived: average of 3 quarters · filed 2021-03-08 | 26.47M shares 10-K · filed 2021-03-08 | |
| 2019-09-30 | 25.58M shares 10-Q · filed 2020-11-09 | 25.40M shares derived: average of 2 quarters · filed 2020-11-09 | 25.21M shares 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | 25.22M shares 10-Q · filed 2020-08-10 | 26.70M shares 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | 26.59M shares 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | 23.81M shares 10-K · filed 2020-03-13 | ||||
| 2018-06-30 | 23.18M shares 10-Q · filed 2019-08-14 | 21.07M shares 10-Q · filed 2019-08-14 | 21.07M shares 10-Q · filed 2018-08-06 | ||
| 2018-03-31 | 20.95M shares 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | 20.03M shares 10-K · filed 2019-03-12 | ||||
| 2017-06-30 | 23.18M shares 10-Q · filed 2018-08-06 | 19.57M shares 10-Q · filed 2018-08-06 | |||
| 2016-06-30 | 13.33M shares 10-Q · filed 2017-08-10 | 11.87M shares 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |